| Transaction Date | Filer | Title | Filing | Transaction Type | Shares Traded | Price | Total Held* |
|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | CVP & Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,184 | -- | 19,100 | |
| Feb 14, 2024 | CVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,598 | -- | 10,789 | |
| Feb 14, 2024 | CVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,623 | -- | 26,547 | |
| Feb 14, 2024 | CVP & Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,184 | -- | 16,363 | |
| Feb 14, 2024 | CVP & Pres. Defense Systems | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,040 | -- | 1,953 | |
| Feb 14, 2024 | CVP & Pres. Defense Systems | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,356 | -- | 5,328 | |
| Feb 14, 2024 | CVP & Pres. Defense Systems | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,435 | -- | 11,190 | |
| Feb 14, 2024 | CVP & Pres. Defense Systems | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,040 | -- | 10,149 | |
| Feb 14, 2024 | Corp VP & General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,919 | -- | 4,298 | |
| Feb 14, 2024 | Corp VP & General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,732 | -- | 3,206 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.